2023
Mortality and Severe Complications Among Newly Graduated Surgeons in the United States
Howard R, Thelen A, Chen X, Gates R, Krumm A, Millis M, Gupta T, Brown C, Bandeh-Ahmadi H, Wnuk G, Yee C, Ryan A, Mukherjee B, Dimick J, George B. Mortality and Severe Complications Among Newly Graduated Surgeons in the United States. Annals Of Surgery 2023, 279: 555-560. PMID: 37830271, PMCID: PMC10939969, DOI: 10.1097/sla.0000000000006128.Peer-Reviewed Original ResearchConceptsYears of practiceSevere complicationsRelative riskGeneral surgeonsIndependent practiceYears of independent practiceCareer surgeonsRelative risk of mortalityAmerican Board of SurgerySurgeon yearsMixed modelsSurgeon characteristicsRate of mortalityMedicare claimsComplicationsSurgeonsPatient outcomesPatientsMortalityAmerican BoardOutcomes
2010
Risk of colorectal cancer in self‐reported inflammatory bowel disease and modification of risk by statin and NSAID use
Samadder N, Mukherjee B, Huang S, Ahn J, Rennert H, Greenson J, Rennert G, Gruber S. Risk of colorectal cancer in self‐reported inflammatory bowel disease and modification of risk by statin and NSAID use. Cancer 2010, 117: 1640-1648. PMID: 21472711, PMCID: PMC3117060, DOI: 10.1002/cncr.25731.Peer-Reviewed Original ResearchConceptsRisk of colorectal cancerAssociated with reduced risk of colorectal cancerHistory of inflammatory bowel diseaseRisk of inflammatory bowel diseaseAssociated with reduced riskLong-term statin useColorectal cancerMolecular Epidemiology of Colorectal Cancer studyPersonal history of inflammatory bowel diseaseIncreased risk of CRCReduced risk of colorectal cancerRelative riskIBD-associated colorectal cancerIncident colorectal cancerNonsteroidal anti-inflammatory drugsUnconditional logistic regressionNonsteroidal anti-inflammatory drug useStatin useModification of riskReduced riskInflammatory bowel diseaseColorectal cancer studyIn-person interviewsNon-IBD colorectal cancersCase-control study